Yuto Takebayashi

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study

Tohru Ohnuma, Aiko Toda, Ayako Kimoto et al. · Clinical Interventions in Aging · 2016 · 77 citations · Full text

Estimated cognitive decline in patients with schizophrenia: A multicenter study

Haruo Fujino, Chika Sumiyoshi, Yuka Yasuda et al. · Psychiatry and Clinical Neurosciences · 2016 · 68 citations

Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia

Narimasa Katsuta, Tohru Ohnuma, Hitoshi Maeshima et al. · Schizophrenia Bulletin · 2014 · 39 citations · Full text

Carbonyl Stress, Psychiatry, Carbonyl Stress Markers +13

Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)

Yuri Hotta, Tohru Ohnuma, Ryo Hanzawa et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2011 · 29 citations

Psychiatry, Psychotic Disorder, Psychiatric Genetics +10

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia

Mayu Takeda, Tohru Ohnuma, Masayoshi Takeuchi et al. · Neuroscience Letters · 2015 · 23 citations · Full text